Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chetan Seshadri

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Nature Communications|January 11, 2022
CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cellsCharlotte A James, Yuexin Xu, Melissa S Aguilar, et al.
The Journal of Infectious Diseases|June 5, 2024
Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in ChildrenMegan A Files, Lauren Gentles, Leanne Kehoe, et al.
Genetic Epidemiology|June 15, 2022
Novel HLA associations with outcomes of Mycobacterium tuberculosis exposure and sarcoidosis in individuals of African ancestry using nearest-neighbor feature selectionBryan A Dawkins, Lori Garman, Nicholas Cejda, et al.
Nature Structural & Molecular Biology|August 10, 2010
Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2Michael G Drage, Han-Chun Tsai, Nicole D Pecora, et al.
Plos One|December 15, 2018
Toll-like receptor chaperone HSP90B1 and the immune response to MycobacteriaAndrew D Graustein, Elizabeth A Misch, Munyaradzi Musvosvi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2018
A Diverse Lipid Antigen-Specific TCR Repertoire Is Clonally Expanded during Active TuberculosisWilliam S DeWitt, Krystle K Q Yu, Damien B Wilburn, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2025
Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturerM Quinn Peters, Amber L Young, Jennifer E Stolarczuk, et al.
The Lancet. Microbe|January 26, 2026
Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trialsChetan Seshadri, JoAnne L Flynn, Pauline Maiello, et al.
Open Forum Infectious Diseases|October 27, 2025
Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine ManufacturerM Quinn Peters, Amber L Young, Jennifer E Stolarczuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2021
T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette-Guérin VaccinationErik D Layton, Soumik Barman, Damien B Wilburn, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Nature Communications|January 11, 2022
CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cellsCharlotte A James, Yuexin Xu, Melissa S Aguilar, et al.
The Journal of Infectious Diseases|June 5, 2024
Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in ChildrenMegan A Files, Lauren Gentles, Leanne Kehoe, et al.
Genetic Epidemiology|June 15, 2022
Novel HLA associations with outcomes of Mycobacterium tuberculosis exposure and sarcoidosis in individuals of African ancestry using nearest-neighbor feature selectionBryan A Dawkins, Lori Garman, Nicholas Cejda, et al.
Nature Structural & Molecular Biology|August 10, 2010
Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2Michael G Drage, Han-Chun Tsai, Nicole D Pecora, et al.
Plos One|December 15, 2018
Toll-like receptor chaperone HSP90B1 and the immune response to MycobacteriaAndrew D Graustein, Elizabeth A Misch, Munyaradzi Musvosvi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2018
A Diverse Lipid Antigen-Specific TCR Repertoire Is Clonally Expanded during Active TuberculosisWilliam S DeWitt, Krystle K Q Yu, Damien B Wilburn, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2025
Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturerM Quinn Peters, Amber L Young, Jennifer E Stolarczuk, et al.
The Lancet. Microbe|January 26, 2026
Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trialsChetan Seshadri, JoAnne L Flynn, Pauline Maiello, et al.
Open Forum Infectious Diseases|October 27, 2025
Infant CD4 T-Cell Response to SARS-CoV-2 mRNA Vaccination Is Restricted in Cytokine Production and Modified by Vaccine ManufacturerM Quinn Peters, Amber L Young, Jennifer E Stolarczuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2021
T Cells Specific for a Mycobacterial Glycolipid Expand after Intravenous Bacillus Calmette-Guérin VaccinationErik D Layton, Soumik Barman, Damien B Wilburn, et al.
Pageof 6